Physician profile
Allen Lea
NPI 1649214594
$1,567.01
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $697 · 2020: $176 · 2021: $694.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $446.38 | 2019-2021 | |
| Novo Nordisk INC | $198.57 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.49 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $162.64 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $136.16 | 2019-2021 | |
| Allergan, INC. | $133.39 | 2019 | |
| Lilly USA, LLC | $89.21 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $43.71 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.71 | 2021 | |
| Merck Sharp & Dohme LLC | $31.66 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $30.60 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $24.90 | 2019 | |
| Amgen INC. | $23.70 | 2019-2020 | |
| Amarin Pharma, INC. | $13.27 | 2020 | |
| Glaxosmithkline, LLC. | $11.33 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $11.29 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Lea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.